Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Pioneering Radiotherapy Technology Treats Multiple Brain Metastases

By HospiMedica International staff writers
Posted on 15 Sep 2008
An innovative radiosurgery system targets treatment beams at tumors while rotating continuously around the patient, makes it possible to complete stereotactic radiosurgery sessions many times faster than conventional techniques that use stationary beams.

The Varian RapidArc stereotactic radiosurgery system is a volumetric arc therapy device that delivers a precisely sculpted three-dimensional (3D) dose distribution with a single 360o rotation of the linear accelerator gantry. More...
It is made possible by a treatment planning algorithm that simultaneously changes three parameters during treatment; leaf interdigitation using a multileaf collimator (MLC), a dynamic "sliding window” approach to beam-shaping, and a patented "gridded gun” to vary the dose rate as a function of the gantry angle.

As a result, a single arc can deliver essentially similar dose distributions compared with intensity-modulated radiation therapy (IMRT) treatment plans that incorporate as many as 36 fields while delivering therapeutic radiation doses to the whole volume of the tumor, rather than slice by slice. Additionally, the treatment-planning algorithm ensures enhanced precision, helping to spare normal healthy tissue. The Varian RapidArc stereotactic radiosurgery system is a product of Varian Medical Systems (Palo Alto, CA, USA).

Researchers from Vrije Universiteit (VU) Medical Center (VUMC; Amsterdam, The Netherlands) began clinical treatments using volumetric modulated arc therapy with the RapidArc in early May 2008 and more than 20 patients have so far been treated. RapidArc was first used to replace IMRT treatments for head and neck, brain, and prostate tumors but from September 2008 onwards RapidArc will replace all conventional treatments at VUMC, since treatments were found to be two to eight times faster than IMRT. VUMC studies with the system were presented at the American Association of Physics in Medicine (AAPM) meeting, held in Houston (TX, USA) in July 2008.

"Our experiences to date have demonstrated that RapidArc appears to be excellent for stereotactic radiosurgery,” said Frank Lagerwaard, M.D., of the department of radiation oncology. "The total time needed for patients to enter and leave the treatment room has decreased to less than 15 minutes as we gain experience. During these treatments the delivery time was just 210 seconds per session.”

By comparison, conventional IMRT stereotactic treatment of three brain metastases using multiple dynamic conformal arcs takes more than 50 minutes from first beam on to last beam off.

Related Links:
Varian Medical Systems
VU medical center


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.